Theresa May has announced the first AI and Data grand challenge mission: to use data, AI and innovation to transform the prevention, early diagnosis and treatment of chronic diseases by 2030.
Topic: Life-sciences-and-healthcareSubscribe to Life-sciences-and-healthcare
AI and Drug Development: The current landscape and IP considerations
AI has the potential to revolutionise the pharmaceuticals industry. Key considerations include how to monetise these innovations and what types of IP protection are available for AI-influenced drug discoveries?